DARC/ACKR1 has also been implicated to affect cancers as a pro-inflammatory cytokine receptor, specifically in lung cancer etiology, BrCa progression by in vitro studies and allele-specific BrCa patient survival [12–14]. The gene discussed is ACKR1; the disease is invasive breast carcinoma.